Ensign Peak Advisors, Inc Repligen Corp Transaction History

Ensign Peak Advisors, Inc

  • $55.3 Billion
  • Q4 2024

A detailed history of Ensign Peak Advisors, Inc transactions in Repligen Corp stock. As of the latest transaction made, Ensign Peak Advisors, Inc holds 138,069 shares of RGEN stock, worth $20.2 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares
138,069
Previous 139,175 0.79%
Holding current value
$20.2 Million
Previous $20.7 Million 4.05%
% of portfolio
0.04%
Previous 0.04%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 13, 2025
SELL
$123.41 - $160.92 $136,491 - $177,977
-1,106 Reduced 0.79%
138,069 $19.9 Million
Q3 2024

Nov 14, 2024
BUY
$119.79 - $167.35 $6.03 Million - $8.43 Million
50,357 Added 56.7%
139,175 $20.7 Million
Q2 2024

Aug 13, 2024
SELL
$120.0 - $182.95 $2.74 Million - $4.17 Million
-22,803 Reduced 20.43%
88,818 $11.2 Million
Q1 2024

May 14, 2024
BUY
$170.78 - $208.42 $10.9 Million - $13.3 Million
63,752 Added 133.18%
111,621 $20.5 Million
Q4 2023

Feb 14, 2024
BUY
$114.17 - $185.35 $270,012 - $438,352
2,365 Added 5.2%
47,869 $8.61 Million
Q3 2023

Nov 13, 2023
BUY
$138.78 - $176.51 $32,613 - $41,479
235 Added 0.52%
45,504 $7.24 Million
Q2 2023

Aug 14, 2023
BUY
$138.42 - $180.31 $480,317 - $625,675
3,470 Added 8.3%
45,269 $6.4 Million
Q1 2023

May 15, 2023
BUY
$154.26 - $198.1 $556,415 - $714,546
3,607 Added 9.44%
41,799 $7.04 Million
Q4 2022

Feb 13, 2023
BUY
$162.42 - $220.56 $48,076 - $65,285
296 Added 0.78%
38,192 $6.47 Million
Q3 2022

Nov 14, 2022
SELL
$160.42 - $256.21 $337,363 - $538,809
-2,103 Reduced 5.26%
37,896 $7.09 Million
Q2 2022

Aug 12, 2022
SELL
$140.68 - $188.02 $714,091 - $954,389
-5,076 Reduced 11.26%
39,999 $6.5 Million
Q1 2022

May 16, 2022
BUY
$161.19 - $257.96 $28,853 - $46,174
179 Added 0.4%
45,075 $8.48 Million
Q4 2021

Feb 11, 2022
SELL
$247.59 - $304.47 $4.51 Million - $5.55 Million
-18,228 Reduced 28.88%
44,896 $11.9 Million
Q3 2021

Nov 12, 2021
BUY
$194.77 - $324.21 $653,453 - $1.09 Million
3,355 Added 5.61%
63,124 $18.2 Million
Q2 2021

Aug 13, 2021
SELL
$165.87 - $220.95 $191,745 - $255,418
-1,156 Reduced 1.9%
59,769 $11.9 Million
Q1 2021

May 12, 2021
BUY
$180.37 - $226.26 $1.39 Million - $1.75 Million
7,722 Added 14.51%
60,925 $11.8 Million
Q3 2020

Nov 12, 2020
BUY
$122.51 - $158.27 $1.17 Million - $1.51 Million
9,521 Added 21.8%
53,203 $7.85 Million
Q2 2020

Aug 12, 2020
BUY
$94.33 - $140.48 $506,080 - $753,675
5,365 Added 14.0%
43,682 $5.4 Million
Q1 2020

May 11, 2020
BUY
$84.96 - $109.14 $195,408 - $251,022
2,300 Added 6.39%
38,317 $3.7 Million
Q4 2019

Feb 14, 2020
BUY
$73.84 - $93.08 $2.66 Million - $3.35 Million
36,017 New
36,017 $3.33 Million

Others Institutions Holding RGEN

# of Institutions
479
Shares Held
55.4M
Call Options Held
310K
Put Options Held
263K
View Full List

About REPLIGEN CORP

RGEN Quotes by TradingView
  • Ticker RGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 55,491,200
  • Market Cap $8.11B
  • Description
  • Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....
More about RGEN
Track This Portfolio

Track Ensign Peak Advisors, Inc Portfolio

Follow Ensign Peak Advisors, Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ensign Peak Advisors, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ensign Peak Advisors, Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email